Skip to main content
Clinical Trials/RPCEC00000329
RPCEC00000329
Completed
N/A

A study to observe patients characteristics, treatment patterns and outcomes in patients with newly diagnosed breast cancer in Latin America. - LatinaBreast

Roche Servicios S.A.0 sitesAugust 6, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
ewly Diagnosed Breast Cancer
Sponsor
Roche Servicios S.A.
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 6, 2020
End Date
July 31, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Histological confirmed newly diagnosed stage I to IV (recurrent or de novo) breast cancer no more than 12 months prior to site activation, although they can have received anti\-cancer treatment during that time

Exclusion Criteria

  • 1\. Patients not receiving treatment for breast cancer with national approved drugs according to standard of care and in line with the current summary of product characteristics (SPC) /local labeling
  • 2\. Patients not receiving the Roche studied medicinal product, but a biosimilar

Outcomes

Primary Outcomes

Not specified

Similar Trials